Category: Latest News
-
CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss
CalciMedica, Inc. (NASDAQ:CALC) shares rose 6.22% in pre-market trading on Tuesday despite the clinical-stage biopharmaceutical company reporting a wider-than-expected second-quarter loss, as investors focused on progress across its pulmonary hypertension programme and regulatory pipeline. CalciMedica reported a quarterly loss of $0.45 per share, compared with the analyst estimate for a loss of $0.26 per share.…
-
Harvard Bioscience beats Q2 estimates and raises 2026 revenue guidance
Harvard Bioscience Inc. (NASDAQ:HBIO) reported better-than-expected second-quarter results on Tuesday and raised its full-year 2026 revenue outlook after stronger demand across its telemetry and cellular and molecular technology businesses. The company posted an adjusted loss of $0.14 per share, considerably narrower than the consensus estimate for a $0.38 loss per share. Revenue increased 11% year…
-
ECARX shares rise as Q2 revenue jumps 45% and losses narrow
ECARX Holdings Inc. (NASDAQ:ECX) shares gained 3.62% in pre-market trading on Tuesday after the automotive intelligence technology company reported strong second-quarter revenue growth, improved margins and a substantially narrower net loss. For the quarter ended June 30, ECARX recorded a loss of $0.03 per share, while revenue climbed 45% year on year to $225.2 million…
-
Tesla investors need more Robotaxi scaling evidence, Morgan Stanley says
Tesla (NASDAQ:TSLA) may need to demonstrate clearer progress in scaling its Robotaxi business before investors gain greater confidence in the company’s broader Physical AI strategy, according to Morgan Stanley. In a note to clients on Tuesday, analyst Andrew Percoco said feedback following Tesla’s second-quarter earnings showed investors remain constructive on the long-term opportunity, particularly given…
-
Janus International shares tumble 14% as weak 2026 guidance overshadows earnings beat
Janus International Group, Inc. (NYSE:JBI) shares fell sharply in pre-market trading on Tuesday after the self-storage and commercial building solutions company issued full-year guidance below Wall Street expectations, overshadowing a second-quarter earnings beat. Adjusted earnings per share came in at $0.17 for the quarter ended July 4, 2026, beating the analyst consensus of $0.15 by…
-
Joby Aviation shares fall after $500 million Resonant Sciences acquisition
Joby Aviation (NYSE:JOBY) shares fell 6% on Tuesday after the electric aircraft developer agreed to acquire defense technology company Resonant Sciences for approximately $500 million, significantly expanding Joby’s exposure to the U.S. national security market. Under the definitive agreement, Joby plans to pay approximately $450 million in cash and $50 million in common stock. The…
-
On Holding shares plunge 22% after Q2 sales miss and weaker growth outlook
On Holding (NYSE:ONON) shares plunged on Tuesday after the Swiss sportswear company reported second-quarter revenue below Wall Street expectations and lowered its full-year sales growth forecast. Second-quarter earnings per share came in at CHF 0.31, ahead of the analyst estimate of CHF 0.29. Revenue increased 21.6% on a constant-currency basis to CHF 850.3 million, but…
-
Sono-Tek shares rise after record $3.6 million production line order
Sono-Tek Corporation (NASDAQ:SOTK) shares rose 3.9% in premarket trading on Tuesday after the company secured a $3.6 million purchase order for an advanced manufacturing line designed for medical diagnostic device production. The contract is the largest single integrated production line order in Sono-Tek’s history. While the company has previously received orders with greater overall values,…
-
Wall Street futures edge higher as investors await U.S. inflation data: Dow Jones, S&P, Nasdaq
U.S. stock futures pointed to a modestly higher opening on Tuesday, with Wall Street looking to recover after the major indices finished a volatile Monday session slightly lower. Sentiment improved as crude oil prices retreated substantially from their earlier highs. U.S. crude futures were still up around 0.4% after having surged as much as 3%…
-
Cardinal Health shares rise 4% as profit beats estimates and 2027 outlook tops forecasts
Cardinal Health Inc. (NYSE:CAH) shares advanced in pre-market trading on Tuesday after the healthcare company delivered better-than-expected fourth-quarter earnings and issued fiscal 2027 profit guidance above Wall Street forecasts. Adjusted earnings per share came in at $2.60, exceeding the analyst consensus of $2.41. Revenue reached $63.7 billion, below expectations of $65.22 billion but up 6%…